Related Experiment Video
Updated: Dec 5, 2025

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
Non-Coding RNAs and Hereditary Hemorrhagic Telangiectasia.
Anthony Cannavicci1,2, Qiuwang Zhang2, Michael J B Kutryk1,2
1Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada.
Non-coding RNAs (ncRNAs) are key regulators of gene expression. This review explores their role in hereditary hemorrhagic telangiectasia (HHT), highlighting their potential as diagnostic and pathogenic factors for this vascular disorder.
Area of Science:
- Molecular Biology
- Genetics
- RNA Biology
Background:
- Non-coding RNAs (ncRNAs), including microRNAs (miRs) and long non-coding RNAs (lncRNAs), regulate gene expression post-transcriptionally.
- Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant vascular disorder causing dangerous malformations and bleeding.
- Current pharmacological treatments for HHT are limited, necessitating research into novel therapeutic targets.
Purpose of the Study:
- To review the current literature on the role of ncRNAs in HHT.
- To investigate ncRNAs as potential diagnostic biomarkers for HHT.
- To explore the pathogenic involvement of ncRNAs in HHT development and progression.
Main Methods:
- Literature review of studies investigating ncRNAs in HHT.
- Analysis of ncRNA expression patterns in HHT patients.
- Examination of functional studies on ncRNAs in HHT pathogenesis.
Main Results:
- Emerging evidence suggests specific ncRNAs are dysregulated in HHT.
- ncRNAs show potential as non-invasive diagnostic markers for HHT.
- ncRNAs are implicated in the vascular dysplasia characteristic of HHT.
Conclusions:
- ncRNAs represent a promising area of research for understanding HHT.
- Targeting ncRNAs may offer novel therapeutic strategies for HHT.
- Further investigation into ncRNA function is crucial for HHT management.
More Related Videos
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
lncRNA - Long Non-coding RNAs
Regulation of Angiogenesis and Blood Supply
The Ras Gene
Ras is a...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...